Edition:
United States

Quintiles Transnational Holdings Inc (Q)

Q on New York Consolidated

78.98USD
26 Sep 2016
Change (% chg)

-- (--)
Prev Close
$78.98
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,147,183
52-wk High
$79.78
52-wk Low
$55.01

Latest Key Developments (Source: Significant Developments)

Quintiles Q2 gaap earnings per share $0.712
Wednesday, 27 Jul 2016 06:00am EDT 

Quintiles Transnational Holdings Inc : Q2 earnings per share view $0.90 -- Thomson Reuters I/B/E/S . For three months ended june 30, 2016, company's service revenues were $1.17 billion which represents growth of 8.6% . Updating full year 2016 service revenue constant currency growth guidance to 6.0% to 7.0% . Is increasing its diluted adjusted eps guidance to $3.78 to $3.88 per share for fy . FY guidance assumes foreign currency exchange rates in effect at end of june remain in effect for remainder of year . Sees full year 2016 constant currency service revenue growth guidance to a range of between 6.0% and 7.0% compared to fy 2015 . Updating 2016 integrated healthcare services constant currency service revenue guidance to a 3.0% to 6.0% decline compared 2015 . FY2016 earnings per share view $3.78, revenue view $4.63 billion -- Thomson Reuters I/B/E/S .FY 2016 diluted gaap eps guidance of $3.26 to $3.41 per share.  Full Article

IMS Health Holdings and Quintiles Transnational Holdings to merge
Tuesday, 3 May 2016 06:00am EDT 

IMS Health Holdings and Quintiles Transnational Holdings:Says IMS Health And Quintiles to merge.IMS shareholders will receive fixed exchange ratio of 0.384 shares of quintiles common stock for each share of IMS stock.Says deal accretive to adjusted diluted EPS in 2017.Expect to achieve annual run-rate cost savings of $100 million by end of year three.Committed financing has been obtained for the deal.Equity market capitalization of joined companies is more than $17.6 billion and enterprise value is more than $23 billion.Ari Bousbib, chairman and chief executive officer of IMS health, will become chairman and chief executive officer of merged organization.Co's board will be comprised of 6 directors appointed by quintiles board of directors and 6 directors appointed by ims health board.Merged company will be named Quintiles IMS Holdings Inc.Upon completion of merger, IMS shareholders will own about 51.4 percent of shares of combined company on a fully diluted basis.Quintiles shareholders will own about 48.6 percent of combined company on a fully diluted basis.IMS health shareholders will receive a fixed exchange ratio of 0.384 shares of quintiles common stock for each share.IMS health shareholders will own about 51.4 percent of shares of combined co on a fully diluted basis.Says combined company expects to maintain dual headquarters in danbury, ct and research triangle park, nc.Companies intend to refinance certain debt in connection with merger.  Full Article

Quintiles Transnational Holdings Inc gives FY 2016 guidance
Thursday, 11 Feb 2016 06:00am EST 

Quintiles Transnational Holdings Inc:Expects to achieve service revenue constant currency growth between 7.0% and 8.5% in FY 2016 compared to full year 2015.Expects FY 2016 diluted adjusted earnings per share of $3.70 to $3.85 per share.  Full Article

Quintiles Transnational Holdings Inc increases share repurchase authorization
Thursday, 5 Nov 2015 04:42pm EST 

Quintiles Transnational Holdings Inc:Board of Directors increased the Company's share repurchase authorization by $300 million for repurchase of the Company's outstanding common stock.  Full Article

Quintiles Transnational Holdings Inc updates FY 2015 service revenue guidance; raises FY 2015 EPS guidance
Wednesday, 28 Oct 2015 06:00am EDT 

Quintiles Transnational Holdings Inc:Updates FY 2015 constant currency service revenue growth guidance to a range of 8.6 pct. - 9.2 pct. compared to FY 2014.Increases FY 2015 its diluted adjusted earnings per share guidance range to $3.27 - $3.33 per share, with diluted GAAP earnings per share between $3.02 - $3.11 per share.  Full Article

Quintiles announces pricing of secondary public offering
Friday, 31 Jul 2015 08:00am EDT 

Quintiles Transnational Holdings Inc:Announces the pricing of an underwritten, secondary public offering of 7,000,000 shares of its common stock.Says by certain of its existing shareholders, including investment funds associated with Bain Capital Investors, LLC, affiliates of TPG Global, LLC, affiliates of 3i Corporation and Temasek Life Sciences Private Limited at a price to the public of $77.85 per share.Says Quintiles will not receive any proceeds from the sale of the shares by the Selling Shareholders in this offering.Says Morgan Stanley is acting as the sole underwriter for this offering.Says the offering is expected to close on Aug. 5.  Full Article

Quintiles Transnational Holdings announces launch of secondary public offering of common stock
Thursday, 30 Jul 2015 04:20pm EDT 

Quintiles Transnational Holdings:Says secondary offering of 7 mln common shares.Quintiles is not offering any stock in this transaction and will not receive any proceeds from the sale of the shares by the Selling Shareholders in the offering.Morgan Stanley is acting as the sole underwriter for this offering.  Full Article

Quintiles Transnational Holdings Inc increases FY 2015 guidance
Wednesday, 29 Jul 2015 06:00am EDT 

Quintiles Transnational Holdings Inc:Says that it is increasing its FY 2015 constant currency service revenue growth guidance to a range of 8.5 pct. - 9.5 pct. compared to FY 2014.Says that it is also increasing its diluted adjusted earnings per share guidance range to $3.09 - $3.19 per share, representing growth of 14.4 pct. - 18.1 pct., with diluted GAAP earnings per share between $2.84 - $2.96 per share.  Full Article

Quintiles Transnational Holdings Inc closes secondary public offering
Tuesday, 19 May 2015 04:05pm EDT 

Quintiles Transnational Holdings Inc:Closes underwritten, secondary public offering of 11,855,050 shares of its common stock by certain of its existing shareholders, at price to the public of $65.00 per share.Says Barclays and Citigroup served as the joint bookrunners for this offering.  Full Article

Quintiles Transnational Holdings prices secondary public offering
Thursday, 14 May 2015 07:30am EDT 

Quintiles Transnational Holdings:Prices an underwritten, secondary public offering of 11,855,050 shares of its common stock by certain of its existing shareholders.Including investment funds associated with Bain Capital Investors, LLC, affiliates of TPG Global, LLC, affiliates of 3i Corporation, Temasek Life Sciences Private Limited and Dennis Gillings, CBE, and his affiliates.Prices at a price to the public of $65.00 per share.Intends to repurchase from the underwriters a number of shares having an aggregate value of approximately $250 million.Quintiles is not offering any stock in this transaction and will not receive any proceeds from the sale of the shares by the Selling Shareholders in this offering.Quintiles' per-share purchase price for the repurchased shares will be the same as the per-share purchase price payable by the underwriters to the Selling Shareholders.Quintiles expects to fund the share repurchase with cash on hand. The repurchase is subject to completion of the offering.Barclays and Citigroup are acting as the joint bookrunners for this offering.Offering is expected to close on May 19.  Full Article